期刊文献+

重组人白细胞介素2-干扰素γ融合蛋白结构建模与活性分析 被引量:2

Structure Modeling and Activity Analysis of Fusion Protein IL-2/IFN-γ
下载PDF
导出
摘要 目的验证重组人白细胞介素2(IL-2)-干扰素γ(IFN-γ)融合蛋白的生物活性。方法应用同源建模,构建了该融合蛋白的三维结构模型,并进行能量优化。结果通过与天然蛋白的三维结构比对,证明各组份在融合蛋白的折叠中,其骨架基本没改变;各组份活性部位并未被屏蔽,且可以与相应的受体对接,最终的结构可靠性评分较高,为其生物学活性提供了结构学依据。分子动力学模拟显示,融合蛋白的连接肽具有一定柔性,为融合蛋白两个组份分别行使各自功能提供了基础。结论重组人IL-2-IFN-γ融合蛋白具有天然的IL-2和IFN-γ的生物学活性。 Objective To validate the biological activity of fusion protein of interleukin-2 (IL-2) and interferon-γ (IFN-γ). Methods By using the homology modeling, a three-dimensional structure model was established, and protein energy was optimized. Results Compared with natural IL-2 or IFN-γ, the structure of fusion protein was not changed, their active sites were not covered, and could be docked into their receptors preferably. Molecular dynamics simulations showed that linker peptide of fusion protein had much flexibility and laid the basis for respective biological functions of the two components, i.e. IL2 and IFN-γ. Conclusion Recombinant protein of IL-2 and IFN-γhas biological activities of natural IL-2 and IFN-γ.
机构地区 解放军
出处 《华南国防医学杂志》 CAS 2010年第2期84-86,共3页 Military Medical Journal of South China
基金 国家"863"课题基金资助项目(2002AA2Z3317)
关键词 蛋白质结构预测 同源建模 分子对接 分子动力学模拟 融合蛋白 Protein structure prediction Homology modeling Molecular docking Molecular dynamics simulations Fusion protein
  • 相关文献

参考文献13

  • 1何晓嫱,陈光明,黄英,杨富强,吴乐园,莫国玉.治疗型双质粒HBV DNA疫苗的构建及其鉴定[J].解放军医学杂志,2003,28(6):493-497. 被引量:15
  • 2Altschul S,Madden T,Schaffer A,et al.Gapped BLAST and PSI-BLAST:a new generation of protein database search programs[J].Nucleic Acids Res,1997,25(17):3389-3402. 被引量:1
  • 3Fiser A,Do RK,Sali A.Modeling of loops in protein structures[J].Protein Science,2000,9(9):1753-1773. 被引量:1
  • 4Shindyalov IN,Bourne PE.Protein structure alignment by incremental combinatorial extension (CE) of the optimal path[J].Protein Eng,1998,11(9):739-747. 被引量:1
  • 5Sayle RA,Milner-White EJ.RASMOL:biomolecular graphics for all[J].Tends Biochem Sci,1995,20(9):374. 被引量:1
  • 6DeLano WL.The PyMOL Molecular graphics system[EB/OL].(2002-12-12)[2009-12-10].http://www.pymol.org. 被引量:1
  • 7Laskowski RA,MacArthur MW,Moss DS,et al.PROCHECK:a program to check the stereochemical quality of protein structures[J].J Appl Cryst,1993,26:283-291. 被引量:1
  • 8Ritchie DW,Kemp,GJ.Protein docking using spherical polar Fourier correlations[J].Proteins,2000,39(2):178-194. 被引量:1
  • 9Mintseris J,Weng Z.Atomic contact vectors in protein-protein recognition[J].Proteins,2003,53(3):629-639. 被引量:1
  • 10Lindahl E,Hess B,van der Spoel D.GROMACS 3.0:A package for molecular simulation and trajectory analysis[J].J Mol Mod,2001,7 (8):306-317. 被引量:1

二级参考文献12

  • 1Davis HL, Michel ML, Whalen RG. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet, 1993,2(11):1847. 被引量:1
  • 2Roy MJ, Wu MS, Barr LJ et al. Induction of antigen-specific CD8^+ T cell, and protective levels of antibody in human by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine, 2000,19(7-8):764. 被引量:1
  • 3Chow YH, Chiang BL, Lee YL et al. Development of Th1 and Th2 populations and the nature of immune responses to hepatitis B virus DNA vaccines can be modulated by codelivery of various cytokine genes. J Immunol, 1998,160(3), 1320. 被引量:1
  • 4Kim J J, Nottingham LK, Tsai A et al. Antigen-spedfic humoral and cellular immune responses can be modulated in rhesus macaques through theuse of IFN-gamma, IL-12, or IL-18 gene adjuvants. J Med Primatol,1999,28(4-5) :214. 被引量:1
  • 5Kim JJ, Yang JS, Manson KH et al. Modulation of antigen specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-γ, or IL-4 gene adjuvants. Vaccine, 2001,19(17-19) :2496. 被引量:1
  • 6Tong S, Li J, Vitvitski L et al. Active hepatitis B virus replication in the presence of anti-HBe is associated with viral variants containing an inactive pre-C region. Virology, 1990,176(2) :596. 被引量:1
  • 7Taniguchi T, Matsui H, Fujita T et al. Structure and expression of a cloned cDNA for human interleukin-2. Nature, 1983,302(5906) : 305. 被引量:1
  • 8Gray PW, Goeddel DV. Human immune interferon (IFN-gamma) gene sequence and structure Basic Life Sci, 1983,25:35. 被引量:1
  • 9Sato Y, Roman M, Tighe H et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science, 1996,273(5273) :352. 被引量:1
  • 10Milich DR. T-and B-cell recognition of hepatitis B viral antigen, Immunol Today, 1988,9(12) :380. 被引量:1

共引文献14

同被引文献34

  • 1曹广文,杨文国,杜平,王雄彪,张丽云,戚中田.枸杞多糖联合LAK/IL-2疗法对75例晚期肿瘤的疗效观察[J].中华肿瘤杂志,1994,16(6):428-431. 被引量:27
  • 2贺小英,彭树英,杨瑞锋,张涌.猪传染性胃肠炎病毒S与M基因融合表达载体及IRES连接双基因共表达载体的构建[J].中国动物检疫,2006,23(6):34-37. 被引量:3
  • 3Morgan DA, Ruseetti FW, Gallo R [ymphneytes E'om 1976,193 (4257) normal ]lumail 1007-1008. 被引量:1
  • 4Atta] M, Blaise 1), Marit G, el al. Consolidation Irealmenl of a- duh acute lymphoblasti: leukemia: a prospective, randomized trial comparing aBogeneie versus autologous bone marrow transplanta- tion and testing the impact of recombinant interleukin-2 after autol- ogous bone marrow transplantatinn. BGMT (,roup [ J]. Blood, 1995,86(4) :1619-1628. 被引量:1
  • 5Coppin C, Porzsoh F, Awa A, et al. Inmmnotherapy [or advanced renal cell cancer [ J ]. Coehrane Database Syst Rev, 2005 ( 1 ) : CD001425. 被引量:1
  • 6Brivio F, Lissnni P, Rovelli F,et al. EIieets of I1,-2 preoperative itnmtmotherapy on surgery-induced changes in angiogeni: regula- tion and its prevention of VEGF increase and 1L-12 decline[ J ]. Hepatogastroenterology, 2002,49 ( 44 ) :385-387. 被引量:1
  • 7Kawata A, Une Y, Hosokawa M, et al. Adjuvant chemoimmmm- therapy for hepatocellular caminoma patients. Adriamyein, inter- leukin-2, and lymphokine-aclivaled killer cells versus adriamycin alone[Jj. Am J Clin Oncol, 1995,18(3) :257-262. 被引量:1
  • 8Date K, Matsumoto K, Shimura H, el al. [tGF/NK4 is a speciEc anlagonist [})r ,()leiotrophi(: actions of het)ato(.yle growth l'a(:tor[J]FEBS Lett, 1997,420( 1 ) :1-6. 被引量:1
  • 9Date K, Matsumoto K, Kuba K, et al. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepato- cyte growth factor [ J ]. Oncogene, 1998,17 ( 23 ) : 3045-3054. 被引量:1
  • 10Okasora T, Jo JI, Tabata Y. Augmented anti-tumor therapy through natural targetability of maerophages genetically engineered by N K4 plasmid DNA [ J ]. Gene Ther, 2008,15 (7) :524-530. 被引量:1

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部